Hisamitsu Pharmaceutical Company Inc Unsponsored ADR
HTSUYStockOTCGREY
$2.94 ▲ +0.00%
Jun 12, 2026
H
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR
$2.94 ▲ +0.00%
Jun 12, 2026
HTSUYStockOTCGREY

About the company

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. As of February 19, 2026, Hisamitsu Pharmaceutical Co., Inc. operates as a subsidiary of Taiyo Kosan Co., Ltd.

Arberion
Loading market data